Our Philosophy About Pancreatic Cancer
Pancreatic cancer is a serious disease. Taking an aggressive rational stance against pancreas cancer, at the earliest possible time, supported by the best medical team, and treated in the most appropriate manner gives the best chance for pancreatic cancer survival. We believe in strong patient-physician bonds, scientifically-based pancreatic cancer treatment, and that comfort can come from knowing that everything that reasonably can be done – is being done. That the best approach is meeting cancer of the pancreas head-on and armed with the best available information.
Recently, a seasoned specialist told us that we had the highest social good to donation ratio that they had ever seen in any non-profit. We put all donations to serious use toward the mission of fighting pancreatic cancer. Less than 8% of donated funds are used for management expenses.
Check out a new exciting Nonprofit, the Suzanne Wright Foundation !
CodePurpleNow is their campaign inspired by Suzanne Wright and her fight against pancreatic cancer. During her lifetime, Suzanne dedicated herself to the most vulnerable among us. After her diagnosis, she made it her mission to fight pancreatic cancer with that same determination. More Here
Speak with a Survivor:
Call 1-800-433-0464 for a free service that will place you in contact with a fellow survivor, or to volunteer to contact someone more recently diagnosed.
Check out our latest Pancreatic Cancer Blog entry !
Since the mid-1990s, teams affiliated with Dr. Daniel Von Hoff have ushered in two of the three key advances in the first-line treatment of advanced pancreatic cancer (ductal adenocarcinoma of the pancreas). This includes seminal work from a research institute affiliated with the University of Texas at San Antonio on the development of gemcitabine for the treatment of pancreatic cancer, AND per published article in 2013 as acting lead of an international consortium presenting the MPACT study results that represented a formal introduction to the advantages of gemcitabine plus Abraxane (nab-paclitaxel) in the treatment of metastatic pancreatic cancer… More Here